They already have orders. Pricing not far away and first sale will be this year.Then after that.....Ropren market 300K courses per year by 2010 and 1.2M by 2013
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%